EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects

Nadine Wafik Nabih, Mohamed S Nafie, Asaad Babker, Ayman Ali Mohammed Alameen, Sherif Ashraf Fahmy

Nanoscale · 2025

DOI: 10.1039/d5nr03373j ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanoscale, 2025. Verfasst von Nadine Wafik Nabih und 4 weiteren Autor:innen. Beteiligte Einrichtung: Organic and Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Sadat City, Menoufia, 32897, Egypt. Hauptthemen laut MEDLINE: Parkinson Disease, Drug Carriers, Lipids, Nanoparticles. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Alexander von Humboldt-Stiftung, Philipps-Universität Marburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) remains one of the most formidable challenges in central nervous system (CNS) drug delivery due to the restrictive blood–brain barrier (BBB) and limited efficacy of current dopaminergic therapies. Created in BioRender. Fahmy, S. (2025) https://BioRender.com/vsusgrv.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDrug CarriersLipidsNanoparticlesNanostructuresHumansLiposomesBlood-Brain BarrierAdministration, IntranasalAnimalsNeuroprotective AgentsBrain

Substanzen

Drug CarriersLipidsLiposomesNeuroprotective Agents

Autor:innen und Institutionen

  • Organic and Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Sadat City, Menoufia, 32897, Egypt.
  • Department of Chemistry, College of Sciences, University of Sharjah, Sharjah P.O. 27272, United Arab Emirates (UAE). mohamed.elsayed@sharjah.ac.ae.
  • Chemistry Department, Faculty of Science, Suez Canal University, P.O. 41522, Ismailia, Egypt. mohamed_nafie@science.suez.edu.eg.
  • Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.
  • Department of Chemical Pathology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan.

Förderung

  • Alexander von Humboldt-Stiftung
  • Philipps-Universität Marburg

Zitieren

APA

Wafik Nabih, N., Nafie, M. S., Babker, A., Alameen, A. A. M., & Fahmy, S. A. (2025). Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects. Nanoscale. https://doi.org/10.1039/d5nr03373j

Vancouver

Wafik Nabih N, Nafie MS, Babker A, Alameen AAM, Fahmy SA. Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects. Nanoscale. 2025. doi:10.1039/d5nr03373j

BibTeX
@article{WafikNabih2025,
  author = {Wafik Nabih, Nadine and Nafie, Mohamed S and Babker, Asaad and Alameen, Ayman Ali Mohammed and Fahmy, Sherif Ashraf},
  title = {Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects},
  journal = {Nanoscale},
  year = {2025},
  doi = {10.1039/d5nr03373j}
}
Kostenlos starten →